Cargando…
Design and Methodology of a Multicenter Randomized Clinical Trial to Evaluate the Efficacy of Tongmai Jiangtang Capsules in Type 2 Diabetic Coronary Heart Disease Patients
Background: Population-based studies have consistently showed an increased incidence of coronary heart disease and cardiac mortality in patients with type 2 diabetes mellitus (T2DM). Tongmai Jiangtang capsules (TJC) are Chinese patent medicines that have been approved in China for the treatment of d...
Autores principales: | Wang, Yu, Guo, Yilei, Lei, Ye, Huang, Shuwei, Dou, Liping, Li, Chang, Zhao, Buchang, Fu, Wei, Zhou, Peng, Wan, Haitong, Zhao, Mingjun, Yang, Jiehong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209367/ https://www.ncbi.nlm.nih.gov/pubmed/34149404 http://dx.doi.org/10.3389/fphar.2021.625785 |
Ejemplares similares
-
Exploring the potential mechanisms of Tongmai Jiangtang capsules in treating diabetic nephropathy through multi-dimensional data
por: Liu, Yi, et al.
Publicado: (2023) -
Efficacy and safety of Tongmai Jiangtang capsule combined with conventional therapy in the treatment of diabetic peripheral neuropathy: a systematic review and meta-analysis
por: Sun, Lin-xi, et al.
Publicado: (2023) -
Effects of Guanxinshutong Capsules as Complementary Treatment in Patients With Chronic Heart Failure: Study Protocol for a Randomized Controlled Trial
por: Wang, Yu, et al.
Publicado: (2021) -
Jiangtang Tongmai Prescription Reduced Diabetic Lung Injury Through SnoN and TGF-β1/Smads Signaling Pathway
por: Ding, Nian, et al.
Publicado: (2022) -
Naoxintong Capsule Alternates Gut Microbiota and Prevents Hyperlipidemia in High-Fat-Diet Fed Rats
por: Lu, Yihang, et al.
Publicado: (2022)